From the Division of Gastroenterology, Hepatology & Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA.
University of Pennsylvania - Perelman School of Medicine, Philadelphia, PA.
J Pediatr Gastroenterol Nutr. 2023 Dec 1;77(6):698-702. doi: 10.1097/MPG.0000000000003923. Epub 2023 Aug 23.
Gluten challenge is an essential clinical tool that involves reintroducing or increasing the amount of gluten in the diet to facilitate diagnostic testing in celiac disease (CD). Nevertheless, there is no consensus regarding the applications of gluten timing, dosing, and duration in children. This review aims to summarize the current evidence, discuss practical considerations, and proposes a clinical algorithm to help guide testing in pediatric patients. Childhood development, social circumstances, and long-term health concerns must be considered when identifying a candidate for gluten challenge. Based on previous studies, the authors suggest baseline serology followed by a minimum of 3-6 grams of gluten per day for over 12 weeks to optimize diagnostic accuracy for evaluation of CD. A formal provider check-in at 4-6 weeks is essential so the provider and family can adjust dosing or duration as needed. Increasing the dose of gluten further may improve diagnostic yield if tolerated, although in select cases a lower dose and shorter course (6-12 weeks) may be sufficient. There is consensus that mild elevations in celiac serology (<10 times the upper limit of normal) or symptoms, while supportive are not diagnostic for CD. Current North American Society for Pediatric Gastroenterology, Hepatology and Nutrition guidelines recommend histologic findings of intraepithelial lymphocytosis, crypt hyperplasia, and villous atrophy as the accurate and most appropriate endpoint for gluten challenge.
麸质激发试验是一种重要的临床工具,它涉及重新引入或增加饮食中的麸质含量,以促进乳糜泻(CD)的诊断性检测。然而,目前对于儿童中麸质时间、剂量和持续时间的应用还没有共识。本综述旨在总结目前的证据,讨论实际注意事项,并提出一个临床算法,以帮助指导儿科患者的检测。在确定进行麸质激发试验的候选者时,必须考虑儿童的发育、社会环境和长期健康问题。根据之前的研究,作者建议进行基线血清学检查,然后每天至少摄入 3-6 克麸质,持续 12 周以上,以优化 CD 的诊断准确性。在 4-6 周时进行正式的提供者检查至关重要,以便提供者和家属可以根据需要调整剂量或持续时间。如果耐受,进一步增加麸质剂量可能会提高诊断效果,但在某些情况下,较低剂量和较短疗程(6-12 周)可能就足够了。目前,北美儿科学会胃肠病学、肝病学和营养学指南一致认为,乳糜泻的血清学检测(<10 倍正常值上限)或症状轻度升高虽然具有支持性,但不足以诊断 CD。当前的北美儿科学会胃肠病学、肝病学和营养学指南建议上皮内淋巴细胞增多、隐窝增生和绒毛萎缩的组织学发现作为麸质激发试验的准确和最合适的终点。